NeuroMetrix clears final FDA hurdle to market Sensus device

12/3/2012 | American City Business Journals

The FDA has cleared NeuroMetrix to market a disposable electrode that works with the firm's Sensus pain management device, which received clearance from the agency in August. The Sensus system employs electromagnetic nerve stimulation to treat leg pain in patients with diabetic peripheral neuropathy and is targeted for release before the end of 2012.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX